Iniparib (BSI-201)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Iniparib (BSI-201), covering 2013-09-19 to 2014-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]